<DOC>
	<DOCNO>NCT00464568</DOCNO>
	<brief_summary>This current study plan dedicate pharmacodynamic ( effect drug body ) study investigate dose response rhinitic subject dose GSK256066 proven work ( 200mcg ) expect ( 50mcg ) work . This study also aim investigate low end predict therapeutic range .</brief_summary>
	<brief_title>A 5-way Treatment Period Trial Single Doses Intranasal GSK256066 Patients With Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>6- ( ( 3- ( ( dimethylamino ) carbonyl ) phenyl ) sulfonyl ) -8-methyl-4- ( ( 3-methyloxyphenyl ) amino ) -3-quinolinecarboxamide</mesh_term>
	<criteria>The subject healthy . Body mass index less 29.0 kg/m² , weight range 55.0kg ( female 50kg ) 95.0kg inclusive . They history hayfever ( repeat yearly episode ) . They positive skin prick test grass pollen within 12 month precede screen visit . They positive radioallergosorbent test grass pollen within 12 month precede screen visit . nonsmoker . They must baseline FEV1 &gt; 80 % predict baseline FEV1 ( maximum record value ) / force vital capacity ( FVC ) ( maximum record value ) &gt; 70 % They capable give inform consent They available complete study measurement . Pregnant nursing female . Women childbearing potential unwilling unable use appropriate method contraception . The subject structural nasal abnormality nasal polyposis . Any respiratory disease mild stable asthma control occasional use asneeded shortacting betaagonists associate normal lung function . The subject history drug allergy may contraindicate participation . The subject participate study new molecular entity previous 4 month clinical study previous 3 month The subject concurrently participate another clinical study expose investigational noninvestigational drug device . The subject screening QTc value &gt; 450msec , PR interval outside range 120 240msec ECG suitable QT measurements.In addition subject exclude history atrial ventricular arrhythmia . The subject supine blood pressure persistently high 140/90 millimetre mercury ( mmHg ) screening . The subject donate unit blood ( 450mL ) within previous 3 month intend donate within 3 month complete study . The subject currently take regular ( course ) medication whether prescribed , include steroid , vitamin , herbal remedy ( e.g . St. John 's Wort ) . Paracetamol ( &lt; 2g/day ) occasional need use shortacting beta agonist permit . Past present disease may affect study . outcome The subject regularly , average , drink 4 unit alcohol per day 1 unit = ½ pint beer ( 284mL ) , 1 glass wine ( 125mL ) , 1 measure spirit ( 25mL ) . The subject risk noncompliance study procedures/restrictions . The subject Hepatitis B , Hepatitis C , HIV virus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Seasonal allergic rhinitis ,</keyword>
	<keyword>hayfever</keyword>
</DOC>